ArticleJournal of Taibah University Medical Sciences2025

Outcomes of empagliflozin in nondiabetic fatty liver patients: A randomized controlled trial.

Bahaa Osman Taha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.